Navigation Links
National Stem Cell Holding in Final Stage Negotiations for Exclusive Licensing of its Recently Discovered Biomaterial for Anti-Aging Applications
Date:10/25/2007

This development places National Stem Cell in the sector for Anti-aging products and services, presently a $30 Billion Market, and one of the

Biggest Marketing Opportunities in the U.S. Today

MOUNTAINSIDE, N.J., Oct. 25 /PRNewswire-FirstCall/ -- National Stem Cell Holding, Inc. (OTC Bulletin Board: NHGI - News) today announced that it is currently in final stage negotiations to exclusively license one of its recently discovered biomaterials which holds promise as an effective anti- aging agent and treatment.

This biomaterial appears to promote the skin's natural ability to maintain youthful tone, texture and viscoelasticity. It is one of a group of recently discovered biomaterials, derived from the company's stem cell and progenitor cell lines, that may stimulate a variety of naturally occurring physiological mechanisms that are involved with the skins ability to preserve and repair itself. This group of biomaterials, for which a provisional patent has recently been filed, also holds promise for a broader and more intensive range of applications such as tissue repair for wound care.

Anti-aging is presently a $30 billion market and arguably, one of the biggest market opportunities in the U.S. today. In the next three years, it is expected to grow to $70 billion. There are 75 million Baby Boomers in the U.S. with 53 million between the ages of 40 and 50, according to Government Accounting Office. Every day 11,000 Baby Boomers turn 50 and this trend will continue for the next 10 years.. By 2012, 50 percent of the population will be over age 50; People over 50 years of age control 70 percent of the financial assets in the USA and 50 percent of all discretionary income.

National Stem Cell Holding, Inc. is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. The Company is developing a pipeline of proprietary stem cell therapeutics with particular focus on diabet
'/>"/>

SOURCE National Stem Cell Holding, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. National Instruments DIAdem -- Complete Your Technical Data Management Framework with Powerful Off-line Analysis, Visualization, and Report Generation
2. Schneider National exec joins TrafficCast board
3. Olympics of biotechnology has international flavor
4. Wisconsin professors elected to National Academy of Sciences
5. CIO Leadership Series: Judy Lemke, Schneider National
6. National angel investment grew 11 percent in `06
7. National broadband policy: Lets get it right this time
8. National Academies induct five UW researchers
9. Traffic data firm navigates international business
10. National Bio and Agro Defense fits Wisconsin
11. CATI takes tech transfer model national

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Dec. 3 VIA Pharmaceutic...y focused on the development of compounds for the ... today announced that it has completed the last pa...of VIA-2291. ,, The FDG-PET trial enrolled 52 ...US and Canada including Massachusetts General Hosp...
(Date:12/3/2009)... DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Sus...enzhen Beike Biotechnology Co. Ltd.,( http://www.b...Risk Diabetic,Foot Care in New Delhi, India, Novem...esearch and regenerative medicine company. , ...ry Association (IPA), aimed,to help podiatrists an...
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces... its catalogue: ,, Drug Discovery Technologies...ities ,, http://www.reportlinker.com/p0164246...Market-Trends--Opportunities.html ,, Drug disc...f every pharmaceutical company,s business strategy...
(Date:12/2/2009)..., Gabon, December 2 , - "...lem and Heritage" , Coinciding with the I...he,Gabonese Republic is hosting an international c...feguarding biological resources in Africa. The,con...eaders, ministers,scientific experts, private com...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Libreville International Conference 2-3 June 2010 2
...AL FUELS INDUSTRIES, INC. (Pink Sheets: VGPR) toda... rating for the Company to "Fully Compliant", its ...TC Markets categorizes all securities trading over...nform investors whether an issuer has made adequat... Subsequent to NFI,s recent filing, Pink OTC Mark...
...ing Drives Aggressive Conversion Program , , ST. ...rovider of cell culture materials and services for...aceutical industry and a business segment within S...q: SIAL ), today announced it has completed the ...ntinuous milling production site in Lenexa, Kansas...
...ucralose manufacturer Guangdong Food Industry Inst...p;P) today announced that the U.S. International T...ded the target date of its final decision in the s...tion 337 patent dispute (docket# 337-TA-604) was f...ate & Lyle Corporation (T&L) , ...
Other Biology Technology:Pink OTC Markets Moves Natural Fuels Industries to Top Tier 2SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free 2SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free 3SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free 4GDFII/L&P Confirms Target Date Extension Of U.S. ITC Sucralose Ruling 2
(Date:12/3/2009)... , ALBUQUERQUE, N.M. Most scientists believe tha...lls that signal each other to emit toxins. The sig...ny bacteria must be present to start the process. ...ined that the very first stage of staph infection,...t form, occurs in a single cell and that this indi...
(Date:12/3/2009)... , Spanish researchers have measured CO2 levels f...atmosphere) over a sparsely inhabited rural area n...f their kind in the Iberian Peninsula, show that t...05. , Over recent years, physicists and meteorol...ioxide (CO2) levels, and how these have evolved in...
(Date:12/2/2009)... , PHILADELPHIA Less acculturated Latino men h...ose who are more acculturated to U.S. culture, but...itting smoking. Details of these findings are publ...tion , a journal of the American Association for C...ocus on tobacco. , "Acculturation affects smokin...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2Acculturation affects smoking cessation success among Latinos 2Anthem Blue Cross and Blue Shield in New Hampshire Gives Boost to Help Small Businesses in the Granite State 51933 1Anthem Blue Cross and Blue Shield in New Hampshire Gives Boost to Help Small Businesses in the Granite State 51933 2Anthem Blue Cross and Blue Shield in New Hampshire Gives Boost to Help Small Businesses in the Granite State 51933 3House Health Reform Bill Would Deliver on President Obamas Vision Says Campaign for Americas Future 51930 1New Lewin Report Shows Need for National Medicaid Out of Network Claims Policy 51927 1New Lewin Report Shows Need for National Medicaid Out of Network Claims Policy 51927 2
...d in textbooks, are essential for eukaryotic cells...ts of energy as they use oxygen. However, some euk...mans--such as Entamoeba histolytica, the causal ag...t are too oxygen poor to support this process. Nev...terious organelle, called a mitosome, that is evol...
...ate student may have figured out why rates of exti... marine life during one of the greatest ice ages o...to 290 million years ago, late in the Paleozoic Er... forms that did survive during this era were singu...mperature and sea levels. Those that were not died...
...identifies 34 regions worldwide where 75 percent o... amphibians survive within habitat covering just 2...ent to the combined areas of the five largest U.S....cent of the Earth,s surface, an area equivalent in...alysis shows that an estimated 50 percent of all v...
Other Biology News:Low level of extinction during ice age linked to adaptability 2Biodiversity hotspots identify conservation priorities 2Biodiversity hotspots identify conservation priorities 3Biodiversity hotspots identify conservation priorities 4Biodiversity hotspots identify conservation priorities 5
PRO S-7C Stirrer, Ceramic Top, 115 V from PRO Scientific
Agencourt AMPure 450ml Kit from Agencourt Bioscience
Pyrex brand baffled trypsinizing flask, with beaded neck from Sigma-Aldrich
...lizing 50g of purified RNA samples for RT-PCR and ... all of the advantages and applications you expect... be used for enzymatic applications such as RT-PCR...imised for the stabilization of aqueous RNA sample...
Biology Products: